Post by
retiredcf on Jul 03, 2024 6:15am
Another Earnings Assessment
Not so bad. GLTA
EPS of $0.02 missed estimates of $0.0583 and revenues of $43.96M missed estimates of $44.81M. Sales grew by 7%, but its SaaS revenue grew by 27% for the quarter, and its SaaS subscription bookings grew by 108%. Gross margins increased to 47% from 45% in the prior year, and management updated guidance for FY2025 calling for 7% to 9% revenue growth, 30% to 32% SaaS revenue growth and 8% to 9% Adjusted EBITDA margins. It has a solid sales pipeline and management is emphasizing on refining its SaaS software, deepening its healthcare vertical, and expanding its footprint in the European markets. Overall, these were decent results and the stock is reacting positively to the numbers and guidance. (5iResearch)